arrow
Back
R

Robert J. Motzer

Memorial Sloan Kettering Cancer Center

148H-index
1.6KPaper Count
12.4WCitation Count
Published Papers 390
Publication Date
Real-world treatment patterns and outcomes in metastatic clear cell renal cell carcinoma following immune checkpoint inhibitor progression (2018-2023)
err2026-09-15
err0
errOAAI
errNeil J Shah; Rahul Ravilla; Andrew J Osterland; Karen Todoroff; Ching-Yu Wang; Pratik Rane; Hakim Saal; Paul R Conkling; Ding Wang; Robert J Motzer
errShare
errSave
34 Belzutifan Plus Lenvatinib Versus Cabozantinib in Post–PD-(L)1 Renal Cell Carcinoma: Health-Related Quality-of-Life Outcomes in the Phase 3 LITESPARK-011 Study
err2026-09-02
err0
errOAAI
errManuela Schmidinger; Daniel Y C Heng; Ray McDermott; Se Hoon Park; Mauricio Burotto; Roberto Iacovelli; Elena Verzoni; Masatoshi Eto; Hernan J Cutuli; Bogdan Zurawski; Camillo Porta; Sylvie Rottey; Ray Manneh Kopp; Guillermo de Velasco; Todd L Saretsky; Sammy Yuan; Rodolfo F Perini; Donna Vickery; Cristina Suarez; Robert J Motzer
errShare
errSave
57 Final Analysis of the TiNivo-2 Phase 3 Trial: Long-term Outcome of Tivozanib (Tivo) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
err2026-09-02
err0
errOAAI
errRobert Motzer; Bradley McGregor; Laurence Albiges; Javier Molina-Cerrillo; Phillipe Barthelemy; Maria Bourlon; Benjamin Garmezy; Sheik Emambux; Arnab Basu; Raffaele Ratta; Pedro Barata; Jeffrey Yorio; Helen Moon; Alex Chehrazi-Raffle; Roberto Iacovelli; Ralph Hauke; Rana McKay; Kathryn Beckermann; Moshe Ornstein; Toni Choueiri
errShare
errSave
78 Dietary Fructose Intake and Tumoral Fructose-Metabolism Gene Expression in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Blockade
err2026-09-02
err0
errOAAI
errAntonio Ocejo; Stanley Liang; Carlene Gonzalez; Allen Mena; Nicholina Metzer; Cihan Duzgol; Jeeban P Das; Ashley Regazzi; Bradley Reinfeld; Sahil D Doshi; Phillip Rappold; Maria I Carlo; Darren R Feldman; Neil J Shah; Jonathan E Rosenberg; Robert J Motzer; Gopa Iyer; Martin H Voss; Ritesh R Kotecha; Brendan J Guercio
errShare
errSave
1 Pembrolizumab Plus Belzutifan Versus Pembrolizumab Plus Placebo as Adjuvant Therapy for Renal Cell Carcinoma: Patient-Reported Outcomes in LITESPARK-022
err2026-09-02
err0
errOAAI
errThomas B Powles; Toni K Choueiri; Jose A Karam; Cristina Suarez; Wesley Yip; Rana R McKay; Thomas Ferguson; Pooja Ghatalia; Christian Caglevic; Jad Chahoud; Roberto Iacovelli; Hans Hammers; Carlos Rojas; Rui Kang; Todd L Saretsky; Manish Sharma; Joseph E Burgents; Robert J Motzer
errShare
errSave
4 Baseline and Early On-Treatment Plasma Kidney Injury Molecule-1 (KIM-1) Levels are Associated with Outcomes in Advanced Renal Cell Carcinoma (aRCC)
err2026-09-02
err0
errOAAI
errWenxin Xu; Habib Hamidi; Robert J Motzer; Thomas Powles; Laurence Albiges; Marc Machaalani; Svetlana Andrianova; Saurabh Gupta; Venu Valmeekam; Toni K Choueiri; Bradley A McGregor; Andrew Simmons
errShare
errSave
81 Tumor-Informed Circulating Tumor DNA Monitoring in Fumarate Hydratase–Deficient Renal Cell Carcinoma
err2026-09-02
err0
errOAAI
errAntonio Ocejo; Andrea Knezevic; Ayaa Essafi; Sahil D Doshi; Andrew Cornish; Neil J Shah; David H Aggen; Robert J Motzer; A Ari Hakimi; Darren R Feldman; Ritesh R Kotecha; Martin H Voss; Maria I Carlo
errShare
errSave
Identification of key symptoms impacting HRQOL in advanced renal cell carcinoma: nivolumab plus cabozantinib versus sunitinib in CheckMate 9ER
err2026-08-14
err0
errOAAI
errCristiane Bergerot; Shengsheng Yu; Min Yang; Bruno Martins; Mengtian Du; Jose Perez Torrealba; Tasha Hall; Navendu Samant; Robert J Motzer; David Cella
errShare
errSave
Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial
err2026-08-12
err0
PREAI
errRobert J Motzer; Ray McDermott; Se Hoon Park; Mauricio Burotto; Roberto Iacovelli; Elena Verzoni; Cristina Suárez; Masatoshi Eto; Hernan J Cutuli; Camillo Porta; Ray Manneh Kopp; Sylvie Rottey; Guillermo de Velasco; Begoña P Valderrama; Arun A Azad; Ugo De Giorgi; Michel Pavic; Piotr Tomczak; Robert Figlin; Hans M Westgeest
errShare
errSave
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors
errScience
IF45.8
err2026-02-26
err0
PREAI
errSophie A. Hanina; Tyler Park; Michael Lopez; Vinagolu K. Rajasekhar; Jorge Mansilla-Soto; Sascha Haubner; Huiyong Zhao; Friederike Kogel; Sarah Nataraj; Priyam Banerjee; Richard Koche; Pierre-Jacques Hamard; Zeynep C. Tarcan; Dennis S. Chi; Dmitriy Zamarin; John H. Healey; Elisa de Stanchina; Robert J. Motzer; Ritesh R. Kotecha; A. Ari Hakimi; Christina S. Leslie; Michel Sadelain
errShare
errSave
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
errShare
errSave
Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone
err2025-12-01
err0
PREAI
errBarbakoff, Daniel; Dawidek, Mark T.; Knezevic, Andrea; Ganz, Marc; Posada, Lina; Khandwala, Yash; Sanmiguel, Andrea Lopez; Reese, Stephen W.; Oparanozie, Arnold; Liso, Nicole; Kotecha, Ritesh R.; Motzer, Robert J.; Reznik, Ed; Coleman, Jonathan; Ostrovnaya, Irina; Voss, Martin H.; Russo, Paul; Hakimi, A. Ari
errShare
errSave
Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma
err2025-11-26
err0
PREAI
errYash S. Khandwala; Stephen W. Reese; Burcin A. Ucpinar; Andrea Knezevic; Lennert Eismann; Chih-Ying Wu; Rohan Mittal; Sahil Doshi; Daniel Barbakoff; Andrea Lopez Sanmiguel; Jonathan Coleman; Mark Dawidek; Robert J. Motzer; Paul Russo; Oguz Akin; Ritesh R. Kotecha; Ying-Bei Chen; Martin H. Voss; A. Ari Hakimi
errShare
errSave
MLH1 Mismatch Repair Deficiency Predicts Exceptional Response to Immune Checkpoint Inhibition in Clear-cell Renal Cell Carcinoma
err2025-11-04
err0
PREAI
errMark T. Dawidek; Lina Posada Calderon; Parantu K. Shah; Rohan Mittal; Burcin Agridag Ucpinar; Ziad Bakouny; Kevin Meli; Eddy Saad; Renée-Maria Saliby; H. Jun Woo; Yash S. Khandwala; Marc Eid; Chris Labaki; Marc Machaalani; Jonathan Coleman; Paul Russo; Ritesh R. Kotecha; Maria I. Carlo; Oguz Akin; David A. Braun; Toni K. Choueiri; Ed Reznik; Ying-Bei Chen; Robert J. Motzer; Martin H. Voss; A. Ari Hakimi
errShare
errSave
Radiomic biomarkers associated with immune checkpoint blockade response for advanced renal cell carcinoma
err2025-11-01
err0
PREAI
errReese, Stephen W.; Barbakoff, Daniel; Ucpinar, Burcin Agridag; Knezevic, Andrea; Fitzgerald, Kelly; Eismann, Lennert; Tehrani, Yousef Mazaheri; Arroyave, Juan Sebastian; Khaleel, Sari; Khandwala, Yash S.; Dawidek, Mark; Motzer, Robert J.; Voss, Martin H.; Russo, Paul; Akin, Oguz; Kotecha, Ritesh R.; Hakimi, A. Ari
errShare
errSave
Novel pembrolizumab-based treatments as first-line therapy in advanced clear cell renal cell carcinoma: Substudy 03A of the open-label, umbrella platform, phase I/II KEYMAKER-U03 trial
err2025-10-18
err0
PREAI
errC. Suarez; C. Rojas; S.J. Shin; P.Yanez Weber; L. Albiges; R. Motzer; H. Hammers; A. Peer; J-L. Lee; W.H. Miller; T. Waddell; V. Neiman; D. Keizman; A.Zwenger Kloster; A. Weickhardt; R. Dziadziuszko; L. Suttner; M. Sharma; J.E. Burgents; T. Powles
errShare
errSave
Integrated efficacy and safety exposure response (ER) analysis of tivozanib (TIVO) for the treatment of renal cell cancer (RCC)
err2025-10-01
err0
errOAAI
errMcGregor, Bradley A.; Choueri, Toni; Albiges, Laurence; Beckermann, Katy; Barthelemy, Philippe; Iacovelli, Roberto; Emambux, Sheik; Molina-Cerrillo, Javier; Garmezy, Benjamin; Barata, Pedro C.; McKay, Rana; Chehrazi-Raffle, Alexander; Hammers, Hans J.; Heng, Daniel Yick Chin; Prins, Klaas; Jin, Bo; Cotreau, Monette; Braendle, Edgar E.; Lebedinsky, Claudia; Motzer, Robert
errShare
errSave
Hypoxia and immune suppression shapes therapeutic outcomes and metastases in clear cell renal cell carcinoma
err2025-10-01
err0
errOAAI
errVuong, Lynda; Cornish, Andrew; Khandwala, Yash; Jiang, Hui; Mascareno, Eduardo; Zheng, Doris; Rappold, Phillip; Leibold, Josef; Sabio, Erich; Weiss, Kate; Gonzalez, Carlene; Rittenhouse, Nicole; Ji, Liangliang; Zhang, Jing; Adlesic, Mojca; Akin, Oguz; Flynn, Jessica; Krishna, Chirag; Sanchez, Alejandro; Natale, Renzo Di; Blum, Kyle; Russo, Paul; Coleman, Jonathan; Frew, Ian; Chowell, Diego; Chen, Yingbei; Solit, David; Ostrovnaya, Irina; Motzer, Robert; Voss, Martin; Kotecha, Ritesh; Chan, Timothy; Kuo, Fengshen; Li, Ming; Hakimi, A. Ari
errShare
errSave
Final results of the phase 3 COSMIC-313 study comparing first-line cabozantinib plus nivolumab and ipilimumab with nivolumab plus ipilimumab in patients with advanced renal-cell carcinoma
err2025-10-01
err0
errOAAI
errAlbiges, Laurence; Motzer, Robert; Aguirre, Sergio Arnoldo Trevino; Kanesvaran, Ravindran; Centkowski, Piotr; Reimers, Melissa A.; Sade, Juan Pablo; Pouessel, Damien; Biscaldi, Elisa; Esteban, Emilio; Angel, Jose; Arija, Arranz; Tykodi, Scott; Ma, Haijun; Zhou, Lei; Losio, Maximiliano van Kooten; Simmons, Andrew; Braun, David; Choueri, Toni; Powles, Thomas
errShare
errSave
Overview of tivozanib (tivo) safety in phase 3 clinical trials in patients with metastatic renal cell carcinoma (mRCC)
err2025-10-01
err0
errOAAI
errBarata, Pedro C.; Rini, Brian; Choueri, Toni; Pal, Sumanta; Barthelemy, Philippe; Iacovelli, Roberto; Mcgregor, Bradley A.; Albiges, Laurence; Molina-Cerrillo, Javier; Garmezy, Benjamin; Hauke, Ralph; Tejwani, Sheela; Basu, Arnab; Moon, Helen; Beckermann, Katy; Ornstein, Moshe; Mckay, Rana; Lebedinsky, Claudia; Braendle, Edgar E.; Motzer, Robert
errShare
errSave